Format
Items per page
Sort by

Send to:

Choose Destination

Links from

Items: 15

1.

Vitamin C and cancer revisited.

Frei B, Lawson S.

Proc Natl Acad Sci U S A. 2008 Aug 12;105(32):11037-8. doi: 10.1073/pnas.0806433105. Epub 2008 Aug 5. No abstract available.

2.

Poly(ethylene glycol) anticancer drug delivery systems.

Greenwald RB.

P R Health Sci J. 2002 Jun;21(2):113-21. Review. No abstract available.

PMID:
12166021
3.

Macromolecular drug carrier systems in cancer chemotherapy: macromolecular prodrugs.

Takakura Y, Hashida M.

Crit Rev Oncol Hematol. 1995 Mar;18(3):207-31. Review. No abstract available.

PMID:
7695833
4.

[Vitamin C in complementary oncology--update 2009].

Gröber U.

Med Monatsschr Pharm. 2009 Jul;32(7):263-7. Review. German.

PMID:
19731754
5.

Antibody-directed enzyme prodrug therapy (ADEPT) for cancer.

Bagshawe KD, Sharma SK, Begent RH.

Expert Opin Biol Ther. 2004 Nov;4(11):1777-89. Review.

PMID:
15500406
6.

Recent advances with monoclonal antibody drug targeting for the treatment of human cancer.

Koppel GA.

Bioconjug Chem. 1990 Jan-Feb;1(1):13-23. Review. No abstract available.

PMID:
2095201
7.

Review of high-dose intravenous vitamin C as an anticancer agent.

Wilson MK, Baguley BC, Wall C, Jameson MB, Findlay MP.

Asia Pac J Clin Oncol. 2014 Mar;10(1):22-37. doi: 10.1111/ajco.12173. Review.

PMID:
24571058
8.

Paclitaxel prodrugs: toward smarter delivery of anticancer agents.

Skwarczynski M, Hayashi Y, Kiso Y.

J Med Chem. 2006 Dec 14;49(25):7253-69. Review. No abstract available.

PMID:
17149855
9.

High-dose vitamin C (ascorbic acid) therapy in the treatment of patients with advanced cancer.

Ohno S, Ohno Y, Suzuki N, Soma G, Inoue M.

Anticancer Res. 2009 Mar;29(3):809-15. Review.

10.

Orthomolecular oncology: a mechanistic view of intravenous ascorbate's chemotherapeutic activity.

González MJ, Miranda-Massari JR, Mora EM, Jiménez IZ, Matos MI, Riordan HD, Casciari JJ, Riordan NH, Rodríguez M, Guzmán A.

P R Health Sci J. 2002 Mar;21(1):39-41. Review.

PMID:
12013679
11.

Parenteral ascorbate as a cancer therapeutic: a reassessment based on pharmacokinetics.

Parrow NL, Leshin JA, Levine M.

Antioxid Redox Signal. 2013 Dec 10;19(17):2141-56. doi: 10.1089/ars.2013.5372. Epub 2013 Jun 19. Review.

12.

Assays for in vitro and in vivo synergy.

Teicher BA.

Methods Mol Med. 2003;85:297-321. Review. No abstract available.

PMID:
12710216
13.

What accounts for the association of vegetables and fruits with lower incidence of cancers and coronary heart disease?

Omenn GS.

Ann Epidemiol. 1995 Jul;5(4):333-5. Review. No abstract available. Erratum in: Ann Epidemiol 1995 Sep;5(5):418.

PMID:
8520718
14.

[Current views on tumor treatment with large doses of vitamin C].

Płomiński P, Stepka K.

Wiad Lek. 1982 Sep 1;35(14):889-93. Review. Polish. No abstract available.

PMID:
6755919
15.

A rational approach for improving the ascorbate antineoplastic activity.

Bocci V, Zanardi I, Travagli V.

Cancer Invest. 2014 Mar;32(3):81-4. doi: 10.3109/07357907.2013.877477. Review. No abstract available.

PMID:
24499108
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk